Bank of America Securities Sticks to Their Hold Rating for Zoetis (ZTS)

Bank of America Securities analyst Michael Ryskin maintained a Hold rating on Zoetis today and set a price target of $140.00.

Claim 50% Off TipRanks Premium

• Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
• Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential

Ryskin covers the Healthcare sector, focusing on stocks such as Zoetis, Illumina, and Idexx Laboratories. According to TipRanks, Ryskin has an average return of 2.4% and a 51.91% success rate on recommended stocks.

In addition to Bank of America Securities, Zoetis also received a Hold from Stifel Nicolaus’s Jonathan Block in a report issued on February 20. However, on February 23, William Blair maintained a Buy rating on Zoetis (NYSE: ZTS).

Based on Zoetis’ latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $2.39 billion and a net profit of $603 million. In comparison, last year the company earned a revenue of $2.32 billion and had a net profit of $581 million

Based on the recent corporate insider activity of 46 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of ZTS in relation to earlier this year. Earlier this month, Kristin Peck, the CEO of ZTS sold 20,000.00 shares for a total of $2,540,864.00.